|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
University of Virginia |
| Information provided by: | University of Virginia |
| ClinicalTrials.gov Identifier: | NCT00601341 |
Purpose
The purpose of this study is to gain a better understanding of the effects of lumbopelvic manual therapy on lower extremity biomechanics and arthrogenic muscle response. As a result of this study, we also hope that physical therapists, athletic trainers, and other physical medicine rehabilitation providers will gain a better understanding of lower extremity injuries and have the scientific evidence to provide patients with techniques which would allow for efficient return to activities of daily living without restrictions and possibly prevent future injuries and minimize risk of osteoarthritis.
The objectives of this study are to:
| Condition | Intervention |
|
Knee Pain Hip Pain Ankle Pain Lumbopelvic Pain |
Other: lumbosacral joint manipulation Other: lumbar passive range of motion Other: No active intervention |
| Study Type: | Interventional |
| Study Design: | Treatment, Open Label, Parallel Assignment, Efficacy Study |
| Official Title: | Effects of Lumbosacral Joint Mobilization/Manipulation on Lower Extremity Muscle Neuromuscular Response |
| Estimated Enrollment: | 276 |
| Study Start Date: | May 2005 |
| Estimated Study Completion Date: | December 2009 |
| Estimated Primary Completion Date: | May 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|
1: Experimental
lumbosacral joint manipulation
|
Other: lumbosacral joint manipulation
lumbosacral joint manipulation
|
|
2: Experimental
lumbar passive range of motion
|
Other: lumbar passive range of motion
lumbar passive range of motion
|
|
3
lie on exam table for 3 minutes
|
Other: No active intervention
Lie on exam table for 3 minutes
|
It is well known that musculoskeletal dysfunction at one joint is not limited to the joint itself and can be related to dysfunction at joints proximal or distal in the kinetic chain. Recent research has focused on the relationship of altered lower extremity kinematics and common musculoskeletal pathologies.
Pain is often associated with musculoskeletal pathologies and is one of the strongest stimuli affecting functional activities in a negative manner. Following injury or chronic dysfunction, inhibitory neurons decrease the ability of musculature to fully recruit excitatory motor neurons. This can lead to aberrant movement patterns and different activation of muscles. Muscle inhibition has been attributed as a possible source of altered motor activation patterns. Pain can be a result or cause of musculoskeletal dysfunction and does not necessarily precede inhibition, but can have a contributing effect. The presence of muscle inhibition is considered a limiting factor in the rehabilitation of musculoskeletal pathologies. If muscle inhibition is properly addressed, individuals and athletes alike, should be able to more appropriately meet the demands of the activities with a decreased risk of future injury.
One technique used to determine presence of muscle inhibition is to measure the ability of the muscle to produce a maximal voluntary isometric contraction and compare values with the ability of the contralateral muscle. Since the contralateral limb may also experience muscle inhibition,it is difficult to obtain an accurate measurement of the amount of muscle inhibition occurring in the ipsilateral limb. A suggested solution is utilize the burst-superimposition technique which provides the muscle with a supramaximal stimulus to recruit any remaining muscle fibers which have not been stimulated.
Treatment of muscle inhibition is multifaceted. Utilization of manual therapy techniques such as joint manipulation or mobilization directed at the lumbopelvic region have been shown to be successful in disinhibiting lower extremity muscles. Previous studies have demonstrated sacroiliac joint manipulation disinhibited the quadriceps muscle in individuals with anterior knee pain. One of the limitations was these studies only observed an immediate decrease of quadriceps inhibition and the duration of the treatment effect was unknown. Effects of disinhibition of other lower extremity muscles and duration of disinhibition have not been determined at this time. It is also unknown what effects manual therapy treatments directed at the lumbopelvic region have on functional activities such as walking, squatting, or ascending/descending stairs. By examining these effects, we will be attempting to provide scientific evidence to validate common clinical practices in rehabilitative medicine.
Eligibility
| Ages Eligible for Study: | 18 Years to 50 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Physician referral to physical therapy for treatment of insidious onset of lumbopelvic or lower extremity musculoskeletal dysfunction or individuals with chronic lumbopelvic or lower extremity musculoskeletal dysfunction not wishing to seek physical therapy services.
Pain reproduced with patella compression, squatting, prolonged sitting, going up or down stairs, or isometric quadriceps contraction.
Exclusion Criteria:
Participants with knee pain which does not fit inclusion criteria.
Participants with signs indicating nerve root compression (contraindication for lumbopelvic joint manipulation)
Participants demonstrating upper motor neuron signs (contraindication to lumbopelvic manipulation)
Contacts and Locations| Contact: Christopher Ingersoll, PhD | 434-924-6187 | cdi9u@virginia.edu |
| Contact: Terry Grindstaff, DPT | 434-243-2419 | tlg6q@virginia.edu |
| United States, Virginia | |||||
| University of Virginia | Recruiting | ||||
| Charlottesville, Virginia, United States, 22908 | |||||
| Contact: Terry Grindstaff, DPT 434-243-2419 tlg6q@virginia.edu | |||||
| Contact: Christopher Ingersoll, PhD 434-924-6187 cdi9u@virginia.edu | |||||
| Principal Investigator: Christopher Ingersoll, PhD | |||||
| University of Virginia |
| Principal Investigator: | Christopher Ingersoll, PhD | University of Virginia |
More Information
| Responsible Party: | University of Virginia ( Christopher Ingersoll, PhD ) |
| Study ID Numbers: | 11730 |
| First Received: | January 14, 2008 |
| Last Updated: | August 6, 2008 |
| ClinicalTrials.gov Identifier: | NCT00601341 |
| Health Authority: | United States: Institutional Review Board |
|
|